+252.8%
PLD vs GSK
+108.8%
+144.0%
-43.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.8% | -0.1% | -0.8% | -0.8% |
| 7D | -2.3% | -1.3% | -0.9% | -1.7% |
| 30D | +1.5% | +2.7% | -1.3% | +0.2% |
| 3M | -8.8% | +2.7% | -11.5% | -10.2% |
| 6M | -7.8% | +3.3% | -11.1% | -9.7% |
| YTD | +2.3% | +6.5% | -4.2% | -1.7% |
| 1Y | +7.1% | +10.7% | -3.5% | +1.2% |
| 3Y | +27.4% | +64.4% | -36.9% | -3.3% |
| 5Y | -1.1% | +46.7% | -47.8% | -22.0% |
| All | +252.8% | +108.8% | +144.0% | +137.8% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling